Hennion & Walsh Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.26M	Sell	420,211 -61,274	-13%	-$821K	0.15%	183
2026 Q1	$7.18M	Buy	481,485 +34,439	+8%	+$767K	0.24%	89
2025 Q4	$11.2M	Buy	447,046 +202,970	+83%	+$3.61M	0.39%	45
2025 Q3	$2.39M	Sell	244,076 -4,466	-2%	-$26.8K	0.09%	299
2025 Q2	$1.06M	Buy	248,542 +6,056	+2%	+$27K	0.04%	481
2025 Q1	$912K	Buy	242,486 +30,240	+14%	+$152K	0.04%	492
2024 Q4	$1.24M	Buy	212,246 +94,651	+80%	+$945K	0.06%	414
2024 Q3	$1.4M	Buy	117,595 +30,283	+35%	+$387K	0.07%	373
2024 Q2	$945K	Buy	+87,312	New	+$947K	0.05%	438

Other funds holding OLMA

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

AFC

Ares Financial Consulting Calabasas, California $139M AUM

Hennion & Walsh Asset Management's OLMA Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 13% in Q2 2026, selling an estimated $821K and leaving 420,211 shares worth $5.26M. The position accounts for 0.15% of the portfolio, ranked #183.

Hennion & Walsh Asset Management first reported a position in OLMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.2M in Q4 2025. 10 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Hennion & Walsh Asset Management held 420,211 shares of Olema Pharmaceuticals worth $5.26M as of Q2 2026.
Hennion & Walsh Asset Management sold 61,274 Olema Pharmaceuticals shares in Q2 2026, an estimated $821K.
Olema Pharmaceuticals made up 0.15% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #183 holding.
Hennion & Walsh Asset Management first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Hennion & Walsh Asset Management's Olema Pharmaceuticals position peaked at $11.2M in Q4 2025.
10 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.